Richard Novak

Richard Novak is a bioengineer and entrepreneur who co-founded and leads Unravel Biosciences, a rare disease therapeutics company built on its BioNAV platform that uses RNA network analysis to ask whether a drug will help real patients before working backward to find its target. A former lead engineer at Harvard's Wyss Institute with 15+ years in drug discovery systems, he also founded the swab company Rhinostics during the COVID-19 pandemic and the science-education nonprofit Future Scientist. Novak holds a PhD in Bioengineering from UC Berkeley and a BS in Biology from Emory, and is a 2024 Termeer Fellow.